- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
AptarGroup Inc (ATR)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/13/2025: ATR (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $161.43
1 Year Target Price $161.43
| 4 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -9.98% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 7.75B USD | Price to earnings Ratio 18.97 | 1Y Target Price 161.43 |
Price to earnings Ratio 18.97 | 1Y Target Price 161.43 | ||
Volume (30-day avg) 7 | Beta 0.51 | 52 Weeks Range 103.23 - 171.96 | Updated Date 11/12/2025 |
52 Weeks Range 103.23 - 171.96 | Updated Date 11/12/2025 | ||
Dividends yield (FY) 1.52% | Basic EPS (TTM) 6.23 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-10-30 | When After Market | Estimate 1.57 | Actual 1.62 |
Profitability
Profit Margin 11.45% | Operating Margin (TTM) 15.15% |
Management Effectiveness
Return on Assets (TTM) 6.84% | Return on Equity (TTM) 15.62% |
Valuation
Trailing PE 18.97 | Forward PE 23.47 | Enterprise Value 8745764343 | Price to Sales(TTM) 2.12 |
Enterprise Value 8745764343 | Price to Sales(TTM) 2.12 | ||
Enterprise Value to Revenue 2.39 | Enterprise Value to EBITDA 10.4 | Shares Outstanding 65619154 | Shares Floating 65073859 |
Shares Outstanding 65619154 | Shares Floating 65073859 | ||
Percent Insiders 1.07 | Percent Institutions 97.34 |
Upturn AI SWOT
AptarGroup Inc

Company Overview
History and Background
AptarGroup Inc. (ATR) was founded in 1992, as a spin-off from Illinois Tool Works. Aptar has grown through acquisitions and innovation, focusing on dispensing, sealing, and active packaging solutions.
Core Business Areas
- Beauty + Home: Dispensing solutions for beauty, personal care, home care, and fragrance markets.
- Pharma: Drug delivery devices and services, including nasal pumps, inhalation devices, and injectable componentry.
- Food + Beverage: Dispensing closures, active packaging solutions, and spray pumps for the food and beverage industries.
Leadership and Structure
The CEO is Stephan B. Tanda. The organizational structure is divisional, with leadership teams focused on each of the core business areas, supported by functional teams (finance, HR, etc.).
Top Products and Market Share
Key Offerings
- Airless Dispensers: Advanced dispensing systems used in cosmetics and skincare. Market share is estimated at 25% within the airless dispenser segment. Competitors include Silgan Dispensing Systems and Quadpack.
- Nasal Spray Pumps: Drug delivery devices for nasal medications. Aptar is a major player in this market, holding an estimated market share of 30%. Competitors include Berry Global and Nemera.
- Active Packaging Solutions: Materials which absorb oxygen and moisture in food packaging. Market share is estimated at 20%. Competitors are Sealed Air and Amcor.
Market Dynamics
Industry Overview
The dispensing and packaging industry is driven by consumer trends, regulatory requirements, and technological advancements. Increased focus on sustainability is a significant trend.
Positioning
AptarGroup is a leader in dispensing and active packaging solutions, known for its innovation, quality, and global reach. The company focuses on high-value-added solutions.
Total Addressable Market (TAM)
The total addressable market for dispensing and packaging is estimated at $100 billion+. Aptar is positioned to capture a portion of this market with its diverse product portfolio.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Global presence
- Diverse product portfolio
- Focus on innovation
Weaknesses
- Exposure to raw material price fluctuations
- Dependence on key customers
- Currency exchange rate risk
Opportunities
- Growth in emerging markets
- Increasing demand for sustainable packaging
- Expansion into new applications
- Strategic acquisitions
Threats
- Intense competition
- Changing regulatory landscape
- Economic downturns
- Disruptive technologies
Competitors and Market Share
Key Competitors
- PKG
- CCL
- SEE
Competitive Landscape
AptarGroup competes on innovation, quality, and global reach. Its competitors offer similar products and services, leading to price competition.
Major Acquisitions
Voluntis
- Year: 2021
- Acquisition Price (USD millions): 84
- Strategic Rationale: Expanding digital health offerings and strengthening pharma segment.
Growth Trajectory and Initiatives
Historical Growth: AptarGroup has experienced moderate growth, driven by organic expansion and strategic acquisitions.
Future Projections: Analyst projections unavailable without real-time data sources.
Recent Initiatives: Recent initiatives include investments in sustainability, expansion into new markets, and product innovation.
Summary
AptarGroup is a strong player in the dispensing and packaging industry with a diverse portfolio and global reach. Its focus on innovation and sustainability is beneficial. However, the company faces risks from raw material prices, competition, and currency fluctuations. Overall, the company is well-positioned for future growth.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Data is based on available information and may be subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About AptarGroup Inc
Exchange NYSE | Headquaters Crystal Lake, IL, United States | ||
IPO Launch date 1993-04-21 | President, CEO & Executive Director Mr. Stephan B. Tanda | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 13500 | Website https://www.aptar.com |
Full time employees 13500 | Website https://www.aptar.com | ||
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

